Tobramycinformulierung

European patent · EP2662093 · In force

Register entry

Publication number
EP2662093
Application number
EP13002039
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 18, 2013
Published
Nov 13, 2013
Granted
Jan 14, 2015
Protection ends at the latest
Apr 17, 2033
Next annual fee due
Apr 30, 2026
IPC classes
A61K 47/12 (2006.01)
A61K 9/08 (2006.01)
A61K 31/7036 (2006.01)
A61K 9/72 (2006.01)
A61K 9/00 (2006.01)
Priority
US 201261644700 P 09.05.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  2. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  3. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  4. Jan 14, 2015

    Granted

    Published in Swissreg on 14.01.2015

Parties

Holder

Norton Healthcare Limited

NORTON HEALTHCARE LIMITED

Regent House 5-7 Broadhurst Gardens, Swiss Cottage London NW6 3RZ, GB

Inventor

Higham, David

Runcorn, WA7 3FA, GB

Hawkins, Kevin

Runcorn, WA7 3FA, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.